CoChat

Outcomes Following Bronchial Artery Embolisation for Haemoptysis in Cystic Fibrosis

Flight, W. G., Barry, P. J., Bright-Thomas, R. J., Butterfield, S., Ashleigh, R., Jones, A. M. · 2017 · CardioVascular and Interventional Radiology

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Background Bronchial artery embolisation (BAE) is recommended for the treatment of massive haemoptysis in cystic fibrosis (CF), but there are no randomised controlled trials of this therapy and its role in sub-massive haemoptysis is unclear. This study aimed to determine the outcomes and safety of BAE in adults with CF.Materials and methods All patients with CF undergoing BAE at our centre between March 2011 and January 2015 were identified at the time of the procedure. Patient records were reviewed at hospital discharge, death or one month post-procedure (whichever was soonest). Follow-up continued to January 2016. Severity of haemoptysis was classified as: massive (>240 ml/24 h or >100 ml/day for ≥2 days), moderate-severe (>20 ml/24 h) or mild (<20 ml/24 h).Results Twenty-seven patients underwent 51 BAE procedures over a median follow-up period of 26 months (range 1-54). Ten patients (37%) required more than one BAE during the study. BAE was performed for massive haemoptysis in 18 cases (35%). Haemoptysis recurred after 31 (61%) of BAE procedures with no difference in recurrence rates between massive and sub-massive haemoptysis. Side effects were reported after 61% of procedures with chest pain the most common adverse event . Mortality after first BAE in the study was 3.9% at 30 days and 14.8% at 12 months. No significant predictors of mortality were identified.Conclusions BAE is often effective in controlling haemoptysis but is associated with considerable morbidity and high recurrence rates.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00270-017-1626-0

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Cited by

See all 28

Metadata

Authors
Flight, W. G., Barry, P. J., Bright-Thomas, R. J., Butterfield, S., Ashleigh, R., & Jones, A. M.
Affiliations
  • Oxford University Hospitals NHS Trust (GB)
  • University of Manchester (GB)
Corresponding author
Flight, W. G.
Venue
CardioVascular and Interventional Radiology
Published
2017-03-13
Volume
40
Issue
8
Pages
1164-1168
ISSN
  • 0174-1551 (ISSN-L)
  • 1432-086X
OpenAlex
W2596555727
Cited by
28
References
23
Citations by year
2025: 2 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 8 · 2020: 2 · 2019: 6
FWCI
1.81
Type
journal article
Language
en
Open access
closed
Locations
  • CardioVascular and Interventional Radiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Tracheal and airway disorders
Keywords
bronchial artery embolization, hemoptysis, cystic fibrosis, procedural safety, post-procedural mortality, chest pain
MeSH terms
Adolescent, Adult, Aged, Bronchial Arteries, Cystic Fibrosis, Embolization, Therapeutic, Female, Follow-Up Studies, Hemoptysis, Humans, Male, Middle Aged, Prospective Studies, Recurrence, Severity of Illness Index, Treatment Outcome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcomes Following Bronchial Artery Embolisation for Haemoptysis in Cystic Fibrosis. https://app.cochat.ai/papers/10.1007/s00270-017-1626-0
The paper
Flight, W. G., Barry, P. J., Bright-Thomas, R. J., Butterfield, S., Ashleigh, R., & Jones, A. M. (2017). Outcomes Following Bronchial Artery Embolisation for Haemoptysis in Cystic Fibrosis. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-017-1626-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.